| CPC A61K 47/6831 (2017.08) [A61K 35/28 (2013.01); A61K 47/68035 (2023.08); A61K 47/6817 (2017.08); A61K 47/6819 (2017.08); A61K 47/6829 (2017.08); A61K 47/6849 (2017.08); A61P 37/06 (2018.01)] | 24 Claims |
|
1. A method of depleting a population of CD45+ cells in a human patient having an autoimmune disease, the method comprising administering to the patient having the autoimmune disease an effective amount of an antibody-drug conjugate (ADC) comprising an anti-CD45 antibody, or antigen binding portion thereof, conjugated to a cytotoxin via a linker,
wherein the cytotoxin is a pyrrolobenzodiazepine dimer, or an indolinobenzodiazepine pseudodimer, wherein:
i) the pyrrolobenzodiazepine dimer has a structure of formula:
![]() wherein the wavy line indicates the attachment point of the linker; or
ii) the indolinobenzodiazepine pseudodimer has a structure of formula:
![]() wherein the wavy line indicates the attachment point of the linker.
|